- Home
- CRSR vs MNMD Comparison
CRSR vs MNMD Comparison
Compare CRSR & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRSR
- MNMD
- Stock Information
- Founded
- CRSR 1994
- MNMD 2019
- Country
- CRSR United States
- MNMD United States
- Employees
- CRSR N/A
- MNMD N/A
- Industry
- CRSR Computer Manufacturing
- MNMD Pharmaceuticals and Biotechnology
- Sector
- CRSR Technology
- MNMD Health Care
- Exchange
- CRSR Nasdaq
- MNMD Nasdaq
- Market Cap
- CRSR 986.3M
- MNMD 960.2M
- IPO Year
- CRSR 2020
- MNMD N/A
- Fundamental
- Price
- CRSR $5.54
- MNMD $11.08
- Analyst Decision
- CRSR Buy
- MNMD Strong Buy
- Analyst Count
- CRSR 7
- MNMD 9
- Target Price
- CRSR $9.71
- MNMD $25.78
- AVG Volume (30 Days)
- CRSR 997.8K
- MNMD 2.0M
- Earning Date
- CRSR 11-04-2025
- MNMD 11-06-2025
- Dividend Yield
- CRSR N/A
- MNMD N/A
- EPS Growth
- CRSR N/A
- MNMD N/A
- EPS
- CRSR N/A
- MNMD N/A
- Revenue
- CRSR $1,449,248,000.00
- MNMD N/A
- Revenue This Year
- CRSR $16.91
- MNMD N/A
- Revenue Next Year
- CRSR $10.27
- MNMD N/A
- P/E Ratio
- CRSR N/A
- MNMD N/A
- Revenue Growth
- CRSR 9.79
- MNMD N/A
- 52 Week Low
- CRSR $5.43
- MNMD $4.70
- 52 Week High
- CRSR $13.02
- MNMD $14.43
- Technical
- Relative Strength Index (RSI)
- CRSR 22.76
- MNMD 41.01
- Support Level
- CRSR $6.10
- MNMD $10.82
- Resistance Level
- CRSR $6.81
- MNMD $11.60
- Average True Range (ATR)
- CRSR 0.36
- MNMD 0.94
- MACD
- CRSR -0.14
- MNMD -0.19
- Stochastic Oscillator
- CRSR 2.65
- MNMD 9.42
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).